Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
BioResearch is following new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic, published by The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA). Please click below link for details.
News
GcLP quality certificate for laboratory procedures
Read more … GcLP quality certificate for laboratory procedures
Study for healthy people with a drug against Covid-19
Read more … Study for healthy people with a drug against Covid-19